The neuromuscular blocking properties of AH 8165 during halothane anaesthesia
- 1 May 1975
- journal article
- clinical trial
- Published by Wiley in Anaesthesia
- Vol. 30 (3) , 333-337
- https://doi.org/10.1111/j.1365-2044.1975.tb00864.x
Abstract
The time to onset, duration, time for reversal, and dose required to abolish twitch response for AH 8165 have been investigated. The drug is shown to be a rapidly acting agent, with a duration of action similar to pancuronium.Keywords
This publication has 8 references indexed in Scilit:
- THE PHARMACOLOGY OF AH 8165: A RAPID-ACTING, SHORT-LASTING, COMPETITIVE NEUROMUSCULAR BLOCKING DRUGBritish Journal of Anaesthesia, 1973
- AH 8165: a new non-depolarizing muscle relaxantAnaesthesia, 1973
- The cardiovascular effects of AH 8165Anaesthesia, 1973
- Short-lasting, Competitive Neuromuscular Blocking Activity in a Series of Azobis-Arylimidazo-[1,2-a]-Pyridinium DihalidesNature, 1972
- AN AZOBIS-ARYLIMIDAZO-PYRIDINIUM DERIVATIVE: A RAPIDLY ACTING NON-DEPOLARISING MUSCLE-RELAXANT: Clinical StudyThe Lancet, 1972
- A NEW DEVICE FOR MONITORING FORCE OF THUMB ADDUCTIONBritish Journal of Anaesthesia, 1970
- Response to tubocurarine chloride and its reversal by neostigmine methylsulfate in manJAMA, 1968
- IRREVERSIBLE TUBOCURARINE NEUROMUSCULAR BLOCK IN THE HUMANBritish Journal of Anaesthesia, 1967